Variable readthrough responsiveness of nonsense mutations in hemophilia A

Abstract excerpt

Readthrough therapy relies on the use of small molecules that enable premature termination codons in mRNA open reading frames to be misinterpreted by the translation machinery, thus allowing the generation of full-length, potentially functional proteins from mRNA carrying nonsense mutations. In patients with hemophilia A, nonsense mutations potentially sensitive to readthrough agents represent approximately 16%...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer-related gene regulation
• Share to Hemophilia Treatment and Research
• Share to Viral Infectious Diseases and Gene Expression in Insects